Rising inflation and the prospect of higher interest rates in the US are pushing many investors to look for sectors where demand is tied to essential services rather than cheap money. Canadian healthcare leaders fit that brief, with balance sheets built to handle bumps in funding costs and ongoing need for treatment and medicine. This article walks through three screened healthcare stocks and why they may deserve a closer look now.
The three healthcare stocks below are just a sample from the broader idea, and the full screen pulled out 2 more companies with equally compelling stories that are not covered here.
If you want to move past a shortlist and start identifying your own highest conviction setups, head straight to the Best Healthcare Stocks screener to filter the universe, analyze individual opportunities, and focus on the healthcare businesses that best fit your criteria.
Aurora Cannabis (TSX:ACB)
Overview: Aurora Cannabis produces pharmaceutical grade medical cannabis and related products for patients, alongside a separate recreational consumer line.
Operations: Aurora Cannabis generates about CA$314 million from cannabis, with revenue mainly sourced from Canada, Europe, Australia and New Zealand.
Market Cap: CA$476 million
Aurora Cannabis fits this healthcare screen through its focus on medical cannabis products and services, and the analyst consensus Narrative on Simply Wall St outlines why international expansion is so important to that story.
"Expansion of Aurora Cannabis’s EU GMP certified production, including the acquired Ontario facility and the planned doubling of output at the Leuna site in Germany, could support higher international volumes that are already priced in through the agreed C$561 million acquisition value. This may pressure future revenue growth expectations if demand or pricing do not keep pace."
What happens to future earnings will depend on how this pressure on its medical-focused revenue mix ultimately affects margins.
If that margin story is what you care about most, read the full narrative for Aurora Cannabis to see how international volumes, funding costs, and patient demand could be decoupling expectations.
Vitalhub (TSX:VHI)
Overview: Vitalhub builds healthcare software that helps hospitals, long term care and community providers manage patient flow, electronic records and care coordination.
Operations: Vitalhub generates about CA$127 million from healthcare software, with key markets in the UK, Canada, Australia and smaller global regions.
Market Cap: CA$486 million
Vitalhub fits the Best Healthcare Stocks theme through its patient flow, EHR and care coordination platforms that help hospitals and care providers run fuller, safer schedules. In addition, the analyst consensus Narrative on Simply Wall St highlights how its newer AI tools build on that base.
"AI enabled products, including imaging referral protocoling, transcription and scribing for community services and internal code refactoring, provide new functionality to win and expand contracts while also targeting lower development and support costs. This combination can support both revenue and margin expansion as uptake broadens."
What happens to future profitability could hinge on how one quiet constraint in its public sector customer base evolves over the next few years.
That quiet constraint is the real hinge, and the full narrative for Vitalhub maps how funding cycles, AI adoption and contract structures could accelerate or stall Vitalhub’s momentum.
High Tide (TSXV:HITI)
Overview: High Tide runs a broad cannabis business, with a dedicated medical cannabis distribution arm that links it directly to healthcare spending.
Operations: High Tide generates about CA$597 million from its Bricks and Mortar segment, with most revenue coming from Canada alongside smaller international contributions.
Market Cap: CA$326 million
High Tide matters for this healthcare screen because its medical cannabis distribution activity connects regulated patient demand with a wider retail and e commerce platform. The analyst consensus Narrative on Simply Wall St describes how that link could become more important over time.
"Expansion of High Tide's Cabana Club and ELITE paid memberships, which reached 2.73 million and more than 186,000 members respectively by Q3 2026, can continue to deepen customer loyalty and support higher revenue per store and more resilient same store sales."
This raises the question of what happens when a less visible shift in how those healthcare linked customers buy and renew prescriptions starts to influence overall pricing power.
As that shift gathers pace for High Tide’s medical buyers, the full narrative for High Tide unpacks how membership economics, pricing power and patient loyalty could be accelerating under the surface.
Seeking Alternatives Beyond Healthcare?
Fresh opportunities move quickly, and the next breakout ideas rarely stay under the radar for long. Scan these focused lists before momentum gets fully caught. Act now.
- Target steady cash generators and stress test balance sheets using the curated list of solid balance sheet and fundamentals (5 results) while it still highlights businesses the crowd has not fully priced.
- Ride structural demand for critical materials by reviewing the hand picked 33 best rare earth metal stocks before sentiment swings and latecomers chase the same producers.
- Track powerful automation trends by running through the focused 87 robotics and automation stocks while the most compelling operators remain under heavier investors’ radar.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com